0
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Biology and management of gastric carcinoid tumours: A review

, &
Pages 669-683 | Received 31 Jul 2002, Accepted 14 Jan 2003, Published online: 04 Dec 2011

References

  • Ahlman H, Dahlström A, Enerbäck L, et al. Two cases of gastric carcinoids: Diagnosis and therapeutic aspects. World J Surg 1988; 12: 356–361.
  • Ahlman H, KOlby L, Lundell L, Olbe L, Wängberg B, Granerus G, Grimelius L, Nilsson 0. Clinical manage-ment of gastric carcinoid tumors. Digestion 1994; 55 Suppl 3: 77–85.
  • Ahlman H, Wängberg B, Nilsson 0, et al. Aspects on diagnosis and treatment of the foregut carcinoid syndrome. Scand J Gastroenterol 1992; 27: 459–471.
  • Annibale B, Delle Faye G, Azzoni C, et al. Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger—Ellison syndrome and antral G-cell hyper-function. Aliment Pharmacol Ther 1994; 8: 95–104.
  • Arnold R. Medical treatment of metastasizing carcinoid tumors. World J Surg 1996; 20: 203–207.
  • Arnold R, Koppel G, Rothmund M. Carcinoid tumors. International symposium on pathology, clinical aspects and therapy. January 13–16,1994, Munich, Germany. Digestion 1994; 55 (Suppl 3).
  • Askanazy M. Zur Pathogenese der Magen-krebse und Ober ihren gelegentlichen Ursprung aus angeboren epithelialen Keimen in der Magenwand. Dtsch Med Wochenschr 1923; 49: 49–51.
  • Azzoni C, Doglioni C, Viale G, et al. Involvement of BCL-2 oncoprotein in the Development of enterochro-maffin-like cell gastric carcinoid. Am J Surg Path 1996; 20: 433–441.
  • Bees N, Ng C, Dick-Mireaux C, Kiely E. Gastric malignant schwannoma in a child. Brit J Radiol 1997; 70: 952–955.
  • Borch K. Epidemiologic, clinicopathologic and eco-nomic aspects of gastroscopic screening of patients with pernicious anaemia. Scand J Gastroenterol 1986; 21: 21–30.
  • Borch K, Renvall H, Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anae-mia. Gastroenterology 1985; 88: 638–648.
  • Borch K, Renvall H, Liedberg G, Andersen BN. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol 1986; 21: 357–363.
  • Borch K, Renvall H, Kullman E, Wilander E. Gastric carcinoid associated with the syndrome of hypergas-trinemic atrophic gastritis. A prospective analysis of 11 cases. Am J Surg Pathol 1987; 11: 435–444.
  • Borch K, Stridsberg M, Burman P, Rehfeld J. Basal chromogranin A and gastrin concentrations in circula-tion correlate to endocrine cell proliferation in type-A gastritis. Scand J Gastroenterol 1997; 32: 198–202.
  • Bordi C. Endocrine tumors of the stomach. Pathol Res Pract 1995; 191: 373–380.
  • Bordi C, D'Adda T, Azzoni C, Ferraro G. Pathogenesis of ECL cell tumors in humans. Yale J Biol Med 1998; 71: 273–284.
  • Bordi C, Azzoni C, Feraro G, et al. Sampling strategies for analysis of enterochromaffin-like cell changes in Zollinger-Ellison syndrome. Am J Clin Pathol 2000; 114: 419–425.
  • Bordi C, Yu J, Baggi M, et al. Gastric carcinoids and their precursor lesions. A histologic and immunohisto-chemical study of 23 cases. Cancer 1991; 67: 663–672.
  • Born J, Tang L, Kidd M, et al. Somatostatin receptor (SSTR) regulation of gastric enterochromaffin-like cell transformation to gastric carcinoid. Surgery 1996; 120: 1026–1032.
  • Capella C, Vassallo G, Solcia E. Light and electron microscopic identification of the histamine-storing agyrophil (ECL) cell in murine stomach and of its equivalent in other mammals. Z Zellforsch Mikrosk Anat 1971; 118: 68–0.
  • Cattan D, Roucayrol AM, Launay TM, et al. Circulating gastrin, endocrine cells, histamine content, and histi-dine decarboxylase activity in atrophic gastritis. Gas-troenterology 1989; 97: 586–596.
  • Creutzfeldt W, Stockmann F. Carcinoids and carcinoid syndrome. Am J Med 1987; 82:4–16.
  • Davies M, O'Dowd G, McEntee G, Hennessy T. Primary gastric carcinoids: A view on management. Br J Surg 1990; 77: 1013–1014.
  • Debelenko L, Emmert-Buck M, Zhuang Z, et al. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 1997; 113: 773–781.
  • De Schryver-Kecskemeti K, Clouse R, Kraus F. Surgical pathology of gastric and duodenal neuroendo-crime tumors masquerading as common polyps. Semin Diagn Pathol 1984; 1: 5–12.
  • De Vries E, Kema I, Sloof M, et al. Recent developments in diagnosis and treatment of metastatic carci-noid tumors. Scand J Gastroenterol 1993; 200 (Suppl): 87–93.
  • Feurle G. Argyrophil cell hyperplasia and a carcinoid tumor in the stomach of a patient with sporadic Zollinger-Ellison syndrome. Gut 1994; 35: 275–277.
  • Genta R. One more dysplasia. Eur J Gastroenterol & Hepatol 2001; 13: 1411–1414.
  • Gilligan CJ, Lawton GP, Tang LH, West AB, Modlin IIVI. Gastric carcinoid tumors: The biology and therapy of an enigmatic and controversial lesion. Am J Gastro-enterol 1995; 90: 338–352.
  • Giordano J. Gastric carcinoid syndrome diagnosed by endoscopy. Am J Gastroenterol 1981; 76: 41–43.
  • Giovannini M, Seitz J, Thomas P, et al. Electronic sectorial ultrasound endoscopy in benign and malignant tumoral pathology of the stomach. Results in 30 patients. Gastroenterol Clin Biol 1993; 17: 26–32.
  • Godwin J. Carcinoid tumors. An analysis of 2837 cases. Cancer 1975; 36: 560–569.
  • Goebel S, Serrano J, Yu F, Gibril F, Venzon D, Jensen R. Prospective study of the value of serum chromo-granin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Cancer 1999; 85: 1470–1483.
  • Gough D, Thompson G, Crotty T, et al. Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinaemia. World J Surg 1994; 18: 472–480.
  • Granberg D, Wilander E, Stridsberg M, Granerus G, Skogseid B, Oberg K. Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids. Gut 1998; 43: 223–228.
  • Green S, Drury J, McCallion J, et al. Carcinoid tumour presenting as recurrent gastric outlet obstruction: A case of long-term survival. Scott Med J 1987; 32: 54–55.
  • Hakanson R, Axelson J, Tielemens Y, Johansson A-G, Willems G, Sundler F. Unilateral vagal denervation suppresses omeprazole-induced trophic effects on the denervated side of the rat stomach. Scand J Gastro-enterol 1992; 27: 65–70.
  • Hakanson R, Owman C, Sporrong B, Sundler F. Electron microscopic identification of the histamine-storing argyrophil (enterochromaffin-like) cells in the rat stomach. Z Zellforsch Mikrosk Anar 1971; 122: 460–466.
  • Hakanson R, Sundler F. Proposed mechanism of gastric carcinoids: The gastrin hypothesis. Eur J Clin Invest 1990; 20: S65–S71.
  • Hague S, Modlin I, West A. Multiple glomus tumors of the stomach with intravascular spead. Am J Surg Path 1992; 16: 291–299.
  • Heidenhain R. Untersuchungen uber den Bau der Labdrusen. Arch Mikro Anat 1870; 6: 368–406.
  • Higham A, Dimaline R, Varro A, et al. Octreotide suppression test predicts beneficial outcome from antrectomy in a patient with gastric carcinoid tumor. Gastroenterology 1998; 114: 817–822.
  • Hirschowitz B, Griffith J, Pellegrin D, Cummings 0. Rapid regression of enterochromaffin-like cell gastric carcinoids in pernicious anaemia after antrectomy. Gastroenterology 1992; 102: 1409–1418.
  • Hurst R, Modlin I. Use of radiolabeled somatostatin analogs in the identification and treatment of somato- Eur J Surg 168 statin receptor-bearing tumors. Digestion 1993; 54: 88–91.
  • Jensen R. Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Medi 1998; 243: 477–488.
  • Jensen R, Norton J. Carcinoid tumors and the carcinoid syndrome. In: DeVita V, Heuman S, Rosenberg S, eds. Cancer: principles and practice of oncology. Philadel-phia: Lippincott-Raven, 1997: 1704–1723.
  • Johansson H, Wilander E. A clinical study of 30 gastric carcinoids. Ups J Med Sci 1982; 87: 135–142.
  • Krenning E, Kooij P, Pauwels S, et al. Somatostatin receptor: Scintigraphy and radionuclide therapy. Diges-tion 1996; 57: 57–61.
  • Krenning E, Kwekkeboom D, Bakker W, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3[-octreotide: the Rot-terdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716–731.
  • Kumashiro R, Naitoh H, Teshima K, Sakai T, Inutsuka S. Minute gastric carcinoid tumor with regional lymph node metastasis. Int Surg 1989; 74:1013–1014.
  • Kuyer P, Rosenbusch G, Yap S, de Boer H. The variable picture of gastric carcinoid. Fortschr Geb Rontgenstr Nuklearmed; 146: 184–188.
  • Lamberts R, Creutzfeldt W, Stockman F, Jacubaschke U, Maas S, Brunner G. Long term omeprazole treatment in man: effects on gastric endocrine cell populations. Digestion. 1988; 39: 126–135.
  • Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia E. Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993; 104: 1356–1370.
  • Larsson C, Skogseid B, ()berg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988; 332: 85–87.
  • Lauffer J, Modlin I, Hinoue T, et al. Pituitary adenylate cyclase-activating polypeptide modulates gastric enter-ochromaffin-like cell proliferation in rats. Gastroenter-ology 1999; 116: 623–635.
  • Lehtola J, Karrttunen T, Krekela I, Niemela S, Rasanen 0. Gastric carcinoids with minimal or no macroscopic lesions in patients with pernicious anaemia. Hepatol-gastroenterology 1985; 32: 72–76.
  • Lehy T, Cadiot M, Ruszniewski P, Bonfils S. Influence of multiple endocrine neoplasia type I on gastric endocrine cell in patients with Zollinger-Ellison syndrome. Gut 1992; 33: 1275–1279.
  • Lehy T, Mignon M, Cadiot G, et al. Gastric endocrine cell behavior in Zollinger-Ellison patients upon long term potent antisecretory treatment. Gastroenterolog. 1989; 96: 1029–1040.
  • Meko J, Norton J. Management of patients with Zollinger-Ellison syndrome. Annu Rev Med 1995; 46: 395–411.
  • Modlin IIVI, Lawton GP, Tang LH, Geibel J, Abraham R, Darr U. The Mastomys gastric carcinoid: Aspects of ECL cell function. Digestion 1994; 55 (Suppl 3): 31–37.
  • Modlin I, Sandor A. An analysis of 8305 cases of carcinoid tumor. Cancer 1997; 79:813–829.
  • Modlin I, Sandor A, Tang L, Kidd M, Zelterman D. A 40 year analysis of 265 gastric carcinoids. Am J Gastroenterol 1997; 92: 633–638.
  • Modlin I, Tang L. The gastric enterochromaffin-like cell: an enigmatic cellular lesion. Gastroenterology 1996; 111: 783–810.
  • Moertel C, Kvols I, O'Connell M, Rubin I. Treatment of neuroendocrine carcinomas with combined. etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 1991; 68: 227–232.
  • Naitoh H, Kumashiro R, Teshima K, et al. A minute, solitary carcinoid of the stomach with a lymph node metastasis: A case report. Gan No Rinsho 1988; 34: 908–913.
  • Nakamura S, Lida M, Yao T, et al. Endoscopic features of gastric carcinoids. Gastrointest Endosc 1991; 37: 535–538.
  • Nosaka T, Habu H, Endo M, Okayasu I. Multiple carcinoid tumors of the stomach with hypergastrinae-mia. Am J Gastroenterol 1992; 87: 766–770.
  • Oberg K, Funa K, Alm G. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome. N Engl J Med 1983; 309: 129–132.
  • Oh S, Chae C, Jang D. Spontaneous gastric carcinoid tumors in the striped field mouse (Apodemus agrarius). J Vet Med Sci 1997; 59: 703–706.
  • Olbe L. Therapeutic applications of Vagotomy. In: Modlin I, ed. Lester Dragstedt Centenary Symposium. New Haven: Yale J Biol Med 1994: 153–158.
  • Papa A, Cammarota G, Tursi A, et al. Histologic types and surveillance of gastric polyps: a seven year clinico-pathological study. Hepatogastroenterology 1998; 45: 579–582.
  • Petersen J, Ferguson D. Gastrointestinal neurofibroma-tosis. J Clin Gastroenterol 1984; 6: 529–534.
  • Picus D, Glazer H, Levitt R, et al. Computed tomography of abdominal carcinoid tumors. AIR 1984; 143: 581–584.
  • Portel-Gomes G, Grimelius L, Johansson H, Wilander E, Stridsberg M. Chromogranin A in human neuro-endocrine tumors: an immunohistochemical study with region-specific antibodies. Am J Surg Pathol 2001; 25: 1261–1267.
  • Purcell R, Singh I, Lewis E, et al. Gastric carcinoid presenting with massive upper gastrointestinal bleed-ing. NY State J Med 1988; 88: 80–81.
  • Rappel S, Altendorf-Hofmann A, Stoite M. Prognosis of gastric carcinoid. Digestion 1995; 56: 455–462.
  • Reinecke P, Borchard F. Pattern of gastric endocrine cells in microcarcinoidosis-an immunohistochemical study of 14 gastric biopsies. Virchows Arch 1996; 428: 237–241.
  • Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology and behavior. World J Surg 1996; 20: 168–172.
  • Rindi G, Luinetti 0, Cornaggia M, Capella C, Solcia E. Three subtypes of argyrophillic carcinoid and the gastric neuroendocrine carcinoma. A clinicopathologi-cal study. Gastroenterology 1993; 104: 994–1006.
  • Roberts L, Marney S, Oates J. Blockade of flush associated with metastatic gastric carcinoid by com-bined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med 1979; 300: 236–238.
  • Rodriguez G, Villamizar R. Carcinoid tumor with skin metastasis. Am J Dermatopathol 1992; 14: 263–269.
  • Ruszniewski P, ltamdani A, Cadiot G, Lehy T, Mignon M, Bonfils S. Long-term treatment with octreotide in patients with the Zollinger-Ellison syndrome. Eur J Clin Invest 1993; 23: 296–301.
  • Sandler M, Snow P. An atypical carcinoid tumor secreting 5-hydroxytryptophane. Lancet 1958; i: 137–139.
  • Sarlomo-Rikala M, Miettinen M. Gastric Schwan-noma-a clinicopathological analysis of six cases. Histopathology 1995; 27: 355–360.
  • Sjöblom S. Clinical presentation and prognosis of gastrointestinal carcinoid tumours. Scand J Gastro-enterol 1988; 23: 779–787.
  • Sjöblom S, Sipponen P, Miettinen M, Karonen S, Jarvinen H. Gastroscopic screening for gastric carci-noids and carcinoma in pernicious anemia. Endoscopy 1988; 20: 52–56.
  • Snow P, Lennard-Jones J, Curzon G, Stacey R. Humoral effects of metastasizing carcinoid tumors. Lancet 1955; (ii): 1004–1009.
  • Solcia E, Bordi C, Creutzfeldt W, Dayal Y. Histo-pathological classification of non-antral gastric endo-crine growths in man. Digestion 1988; 41: 185–200.
  • Solcia E, Capella C, Fiocca R, Rindi G, Rosai J. Gastric argyrophil carcinoidosis in patients with ZE syndrome due to Type I MEN: A newly diagnosed association. Am J Surg Pathol 1990; 14: 503–513.
  • Solcia E, Fiocca R. Sessa F et al. Morphology and national history of gastric endocrine tumors. In: Hakanson R, Sundler F, eds. The stomach as an endocrine organ. Amsterdam: Elsevier Science, 1991: 473–498.
  • Solcia E, Fiocca R, Villani L, Luinetta 0, Capella C. Hyperplastic, dysplastic and neoplastic enterochromaf-fin-like cell proliferations of the gastric mucosa. Classification and Histogenesis. Am J Surg Pathol 1995; 19\(suppl 1): S1–S7.
  • Solcia E, Rindi G, Havu N, et al. Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole. Scand J Gastroenterol 1989; 166 (Suppl): 129–137.
  • Solcia E, Villani L, Luinetti 0, et al. Proton pump inhibitors, enterochromaffin-like cell growth and Heli- cobacter pylori gastritis. Aliment Pharmacol Ther 1993; 1: 25–28.
  • Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy 1995; 27(1): 32–37.
  • Sundler F, Hikanson R. Gastric endocrine cell typing at the light microscopic level. In: Hakanson R, Sundler F, eds. The stomach as an endocrine organ. Amsterdam: Elsevier Science, 1991.
  • Tang L, Luque E, Efstathiou J, et al. Gastrin receptor expression and function during rapid transformation of the enterochromaffin-like cells in an African rodent. Regul Pept 1997; 72: 9–18.
  • Tang L, Modlin I, Lawton G, Kidd M, Chinnery R. The role of TGF-alpha in the enterochromaffin-like (ECL) cell tumor autonomy in an African rodent Mastomys. Gastroenterology 1996; 111: 1212–1223.
  • Thomas RM, Baybick JH, Elsayed AM, Sobin LH. Gastric carcinoids: An immunohistochemical and clinicopathologic study of 104 patients. Cancer 1994; 73: 2053–2058.
  • Tomassetti P, Migliori M, Caletti G, Fusaroli P, Corinaldesi R, Gullo L. Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med 2000; 343: 551–554.
  • Waldum H, Aase S, Kvetnoi I, et al. Neuroendocrine differentiation in human gastric carcinoma. Cancer 1998; 83: 435–444.
  • Wilander E, el-Salhy M, Pitkanen P. Histopathology of gastric carcinoids: A survey of 42 cases. Histopathology 1984; 8: 183–193.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.